Europe Cosmetic Surgery Market Size, Trends and Insights By Procedure Type (Surgical Procedures, Breast Augmentation, Liposuction, Rhinoplasty (Nose Job), Abdominoplasty (Tummy Tuck), Facelift, Eyelid Surgery (Blepharoplasty), Non-Surgical Procedures, Botulinum Toxin (Botox), Dermal Fillers, Chemical Peels, Laser Hair Removal, Microdermabrasion), By Gender (Male, Female), By End-User (Ambulatory Surgical Facility, Hospital and Clinic, Cosmetic Surgical Center, Others), and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Reports Description
As per the current market research conducted by the CMI Team, the Europe Cosmetic Surgery Market is expected to record a CAGR of 10.2% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 23,853.7 Million. By 2033, the valuation is anticipated to reach USD 57,172.8 Million.
The Europe cosmetic surgery market encompasses a wide range of surgical and non-surgical aesthetic procedures to enhance appearance. Key factors driving the market include increasing disposable income, an aging population, and technological advancements leading to safer and more effective treatments. Popular procedures include breast augmentation, liposuction, Botox, and dermal fillers.
The market has rebounded post-COVID-19, with clinics adopting telemedicine and enhanced safety protocols. Leading companies like Allergan, Galderma, and Mentor Worldwide are at the forefront, innovating with new products and minimally invasive techniques to meet the growing demand for cosmetic enhancements across Europe.
Europe Cosmetic Surgery Market – Significant Growth Factors
The Europe Cosmetic Surgery Market presents significant growth opportunities due to several factors:
- Rising Disposable Income: As disposable incomes increase across Europe, more individuals can afford cosmetic procedures, increasing market demand. This economic improvement enables people to invest more in personal aesthetics and wellness, further driving the growth of cosmetic treatments.
- Aging Population: Europe’s significant aging population is driving demand for anti-aging treatments, including facelifts, Botox, and dermal fillers. As people live longer and remain active, the desire to maintain a youthful appearance grows, leading to a higher uptake of various cosmetic procedures aimed at reversing the signs of aging.
- Technological Advancements: Innovations in cosmetic surgery techniques and non-invasive procedures make treatments safer, more effective, and more appealing to a broader audience. Advanced technologies such as laser and ultrasound devices, improved surgical instruments, and cutting-edge implant materials have revolutionized the industry, making procedures less invasive with quicker recovery times.
- Growing Acceptance and Social Influence: Reduced stigma and increased acceptance of cosmetic procedures, driven by social media and celebrity endorsements, encourage more people to undergo these treatments. Platforms like Instagram and YouTube allow influencers to showcase their results, normalizing cosmetic enhancements and making them more mainstream, which significantly boosts market demand.
- Medical Tourism: Countries like Turkey, Hungary, and Poland offer high-quality cosmetic procedures at competitive prices, attracting international patients and boosting local market growth. These destinations provide state-of-the-art facilities and experienced surgeons, combined with affordable pricing, which appeals to patients seeking cost-effective solutions without compromising on quality.
- Expansion of Non-Invasive Treatments: The growing popularity of non-invasive procedures, such as laser treatments and injectables, presents an opportunity for market expansion, as these options appeal to a wider demographic due to their lower risk and shorter recovery times.
Europe Cosmetic Surgery Market – Mergers and Acquisitions
The Europe Cosmetic Surgery Market has seen several mergers and acquisitions in recent years, with companies seeking to expand their market presence and leverage synergies to improve their product offerings and profitability. Some notable examples of mergers and acquisitions in the Europe Cosmetic Surgery Market include:
- In 2024, Lumenis Be UK partnered with Aesthetics Solutions to distribute its portfolio in the UK. Aesthetics Solutions will handle the Lumenis Beauty range, while Lumenis retains distribution of its medical aesthetic products, aiming to enhance market reach and service efficiency.
- In 2021, Establishment Labs S.A.’s collaboration with Ipomia to create post-op bras for Motiva Implants recipients has bolstered its market credibility. This initiative enhances patient support and demonstrates a commitment to improving post-surgery experiences, reinforcing their reputation in the industry.
These mergers and acquisitions helped companies expand their product offerings, improve their market presence, and capitalize on growth opportunities in the Europe Cosmetic Surgery Market. The trend is expected to continue as companies seek to gain a competitive edge in the market.
COMPARATIVE ANALYSIS OF THE RELATED MARKET
| Europe Cosmetic Surgery Market | Cosmetic Surgery Market | US Cosmetic Surgery Market |
| CAGR 10.2% (Approx) | CAGR 11.7% (Approx) | CAGR 5.4% (Approx) |
| USD 57,172.8 Million by 2033 | USD 207.6 Billion by 2033 | USD 36,347.2 Million by 2033 |
Europe Cosmetic Surgery Market – Significant Threats
The Europe Cosmetic Surgery Market faces several significant threats that could impact its growth and profitability in the future. Some of these threats include:
- Regulatory Challenges: Stringent regulations and varying legal frameworks across European countries can pose challenges to market entry and operation. Compliance with safety standards and regulatory approvals adds complexity and may limit innovation.
- Economic Uncertainty: Fluctuations in economic conditions, such as recessions or financial crises, can reduce consumer discretionary spending on elective procedures. Economic downturns may lead to decreased demand for cosmetic surgeries and non-invasive treatments.
- Health Risks and Safety Concerns: Despite advancements, all medical procedures carry inherent risks. Safety concerns, including adverse effects from implants or non-invasive treatments, can impact consumer confidence and deter potential patients from undergoing cosmetic procedures.
- Negative Public Perception: Persistent stigma surrounding cosmetic surgery, influenced by media portrayals and societal norms, may discourage individuals from considering aesthetic enhancements. Misinformation or negative media coverage about botched procedures can also tarnish the industry’s reputation.
- Competition from Alternative Treatments: Non-surgical alternatives, such as cosmetic dermatology procedures (e.g., chemical peels, microdermabrasion) and non-invasive aesthetic treatments (e.g., laser therapy, injectables), pose a competitive threat. These alternatives offer similar results with fewer risks and shorter recovery times, appealing to a broader audience seeking minimally invasive solutions.
Category-Wise Insights
By Procedure Type:
- Surgical Procedures: Surgical procedures in the Europe cosmetic surgery market involve invasive techniques to alter or enhance physical features. Popular surgeries include breast augmentation, liposuction, rhinoplasty, and facelifts. Trends include advancements in surgical techniques for safer and more natural-looking results, growing demand for body contouring procedures, and an increasing preference for minimally invasive approaches to reduce recovery times.
- Non-Surgical Procedures: Non-surgical procedures utilize minimally invasive techniques to enhance appearance without surgery. These include Botox, dermal fillers, chemical peels, laser hair removal, and microdermabrasion. Trends in Europe’s cosmetic market show a rising popularity of non-invasive treatments due to their convenience, lower risks, and minimal downtime. Technological innovations in lasers and injectables continue to drive growth, catering to a broader demographic seeking quick, effective aesthetic enhancements.
By Gender
- Male: In the Europe cosmetic surgery market, male procedures focus on enhancing facial and body features to achieve a more youthful and masculine appearance. Popular treatments include rhinoplasty, liposuction, and gynecomastia surgery. There’s a growing trend among men towards non-invasive procedures like Botox and dermal fillers to reduce wrinkles and enhance facial contours, reflecting a cultural shift towards greater acceptance of male grooming and aesthetic enhancements.
- Female: The Europe cosmetic surgery market for females encompasses a wide range of procedures to enhance facial features, body contours, and overall youthful appearance. Common treatments include breast augmentation, liposuction, and facelifts. Trends show a preference for natural-looking results and a rise in non-invasive procedures such as injectables and laser treatments for skin rejuvenation. Increasingly, women seek personalized treatments that align with their aesthetic goals and lifestyle choices.
By End Users
- Ambulatory Surgical Facility: Ambulatory surgical facilities are outpatient centers where cosmetic surgeries are performed, offering convenience and cost-effectiveness. Trends include a rise in minimally invasive procedures like Botox and fillers due to shorter recovery times.
- Hospital and Clinic: Hospitals and clinics provide a range of cosmetic procedures from surgeries to non-invasive treatments. Trends involve hospitals integrating cosmetic departments, ensuring comprehensive care under medical oversight.
- Cosmetic Surgical Center: Dedicated centers specializing in cosmetic surgeries, offering specialized expertise and advanced technologies. Trends include personalized patient experiences and expanding service portfolios to include non-surgical options.
- Others: This category may include medical spas, aesthetic clinics, and independent practitioners. Trends focus on holistic wellness approaches, combining cosmetic treatments with wellness services like skincare and nutrition counselling.
Report Scope
| Feature of the Report | Details |
| Market Size in 2024 | USD 23,853.7 Million |
| Projected Market Size in 2033 | USD 57,172.8 Million |
| Market Size in 2023 | USD 21,645.8 Million |
| CAGR Growth Rate | 10.2% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Procedure Type, Gender, End-User and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | Europe |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Competitive Landscape – Europe Cosmetic Surgery Market
The Europe Cosmetic Surgery Market is highly competitive, with a large number of key players operating in Europe. Some of the key players in the market include:
- Allergan plc
- Galderma S.A.
- Mentor Worldwide LLC (Johnson & Johnson)
- Merz Pharma GmbH & Co. KGaA
- Sientra Inc.
- Polytech Health & Aesthetics GmbH
- Cynosure LLC (Hologic Inc.)
- Cutera Inc.
- Syneron Medical Ltd. (Candela Corporation)
- Alma Lasers Ltd.
- Lumenis Ltd.
- Straumann Group
- Teoxane Laboratories
- Laboratories Vivacy SAS
- Sinclair Pharma plc
- Others
These companies operate in the market through various strategies such as product innovation, mergers and acquisitions, and partnerships.
Emerging players in the Europe cosmetic surgery market are leveraging innovation to enter the industry. These include startups focusing on advanced technologies such as AI-driven treatment planning, 3D imaging for precise outcomes, and biocompatible materials for implants, aiming to disrupt with cutting-edge solutions that enhance safety and efficacy.
Established leaders like Allergan, Galderma, and Mentor Worldwide dominate by leveraging extensive R&D capabilities, robust distribution networks, and a strong brand reputation. They lead through continuous product innovation, strategic acquisitions, and partnerships, ensuring a comprehensive portfolio of surgical and non-surgical options, thus maintaining market leadership and consumer trust.
The Europe Cosmetic Surgery Market is segmented as follows:
By Procedure Type
- Surgical Procedures
- Breast Augmentation
- Liposuction
- Rhinoplasty (Nose Job)
- Abdominoplasty (Tummy Tuck)
- Facelift
- Eyelid Surgery (Blepharoplasty)
- Non-Surgical Procedures
- Botulinum Toxin (Botox)
- Dermal Fillers
- Chemical Peels
- Laser Hair Removal
- Microdermabrasion
By Gender
- Male
- Female
By End-User
- Ambulatory Surgical Facility
- Hospital and Clinic
- Cosmetic Surgical Center
- Others
Regional Coverage:
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market Research Methodology
- Chapter 2. Executive Summary
- 2.1 Europe Cosmetic Surgery Market, (2024 – 2033) (USD Million)
- 2.2 Europe Cosmetic Surgery Market: snapshot
- Chapter 3. Europe Cosmetic Surgery Market – Industry Analysis
- 3.1 Europe Cosmetic Surgery Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Rising Disposable Income
- 3.2.2 Aging Population
- 3.2.3 Technological Advancements
- 3.2.4 Growing Acceptance and Social Influence
- 3.2.5 Medical Tourism
- 3.2.6 Expansion of Non-Invasive Treatments.
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Procedure Type
- 3.7.2 Market Attractiveness Analysis By Gender
- 3.7.3 Market Attractiveness Analysis By End-User
- Chapter 4. Europe Cosmetic Surgery Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Europe Cosmetic Surgery Market: Company Market Share, 2023
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, collaboration, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Europe Cosmetic Surgery Market – Procedure Type Analysis
- 5.1 Europe Cosmetic Surgery Market Overview: By Procedure Type
- 5.1.1 Europe Cosmetic Surgery Market Share, By Procedure Type, 2023 and 2033
- 5.2 Surgical Procedures
- 5.2.1 Europe Cosmetic Surgery Market by Surgical Procedures, 2024 – 2033 (USD Million)
- 5.3 Breast Augmentation
- 5.3.1 Europe Cosmetic Surgery Market by Breast Augmentation, 2024 – 2033 (USD Million)
- 5.4 Liposuction
- 5.4.1 Europe Cosmetic Surgery Market by Liposuction, 2024 – 2033 (USD Million)
- 5.5 Rhinoplasty (Nose Job)
- 5.5.1 Europe Cosmetic Surgery Market by Rhinoplasty (Nose Job), 2024 – 2033 (USD Million)
- 5.6 Abdominoplasty (Tummy Tuck)
- 5.6.1 Europe Cosmetic Surgery Market by Abdominoplasty (Tummy Tuck), 2024 – 2033 (USD Million)
- 5.7 Facelift
- 5.7.1 Europe Cosmetic Surgery Market by Facelift, 2024 – 2033 (USD Million)
- 5.8 Eyelid Surgery (Blepharoplasty)
- 5.8.1 Europe Cosmetic Surgery Market by Eyelid Surgery (Blepharoplasty), 2024 – 2033 (USD Million)
- 5.9 Non-Surgical Procedures
- 5.9.1 Europe Cosmetic Surgery Market by Non-Surgical Procedures, 2024 – 2033 (USD Million)
- 5.10 Botulinum Toxin (Botox)
- 5.10.1 Europe Cosmetic Surgery Market by Botulinum Toxin (Botox), 2024 – 2033 (USD Million)
- 5.11 Dermal Fillers
- 5.11.1 Europe Cosmetic Surgery Market by Dermal Fillers, 2024 – 2033 (USD Million)
- 5.12 Chemical Peels
- 5.12.1 Europe Cosmetic Surgery Market by Chemical Peels, 2024 – 2033 (USD Million)
- 5.13 Laser Hair Removal
- 5.13.1 Europe Cosmetic Surgery Market by Laser Hair Removal, 2024 – 2033 (USD Million)
- 5.14 Microdermabrasion
- 5.14.1 Europe Cosmetic Surgery Market by Microdermabrasion, 2024 – 2033 (USD Million)
- 5.1 Europe Cosmetic Surgery Market Overview: By Procedure Type
- Chapter 6. Europe Cosmetic Surgery Market – Gender Analysis
- 6.1 Europe Cosmetic Surgery Market Overview: By Gender
- 6.1.1 Europe Cosmetic Surgery Market Share, By Gender, 2023 and 2033
- 6.2 Male
- 6.2.1 Europe Cosmetic Surgery Market by Male, 2024 – 2033 (USD Million)
- 6.3 Female
- 6.3.1 Europe Cosmetic Surgery Market by Female, 2024 – 2033 (USD Million)
- 6.1 Europe Cosmetic Surgery Market Overview: By Gender
- Chapter 7. Europe Cosmetic Surgery Market – End-User Analysis
- 7.1 Europe Cosmetic Surgery Market Overview: By End-User
- 7.1.1 Europe Cosmetic Surgery Market Share, By End-User, 2023 and 2033
- 7.2 Ambulatory Surgical Facility
- 7.2.1 Europe Cosmetic Surgery Market by Ambulatory Surgical Facility, 2024 – 2033 (USD Million)
- 7.3 Hospital and Clinic
- 7.3.1 Europe Cosmetic Surgery Market by Hospital and Clinic, 2024 – 2033 (USD Million)
- 7.4 Cosmetic Surgical Center
- 7.4.1 Europe Cosmetic Surgery Market by Cosmetic Surgical Center, 2024 – 2033 (USD Million)
- 7.5 Others
- 7.5.1 Europe Cosmetic Surgery Market by Others, 2024 – 2033 (USD Million)
- 7.1 Europe Cosmetic Surgery Market Overview: By End-User
- Chapter 8. Europe Cosmetic Surgery Market – Regional Analysis
- 8.1 Europe Cosmetic Surgery Market Regional Overview
- 8.2 Europe Cosmetic Surgery Market Share, by Region, 2023 & 2033 (USD Million)
- 8.3. Europe
- 8.3.1 Europe Europe Cosmetic Surgery Market, 2024 – 2033 (USD Million)
- 8.3.1.1 Europe Europe Cosmetic Surgery Market, by Country, 2024 – 2033 (USD Million)
- 8.3.1 Europe Europe Cosmetic Surgery Market, 2024 – 2033 (USD Million)
- 8.4 Europe Europe Cosmetic Surgery Market, by Procedure Type, 2024 – 2033
- 8.4.1 Europe Europe Cosmetic Surgery Market, by Procedure Type, 2024 – 2033 (USD Million)
- 8.5 Europe Europe Cosmetic Surgery Market, by Gender, 2024 – 2033
- 8.5.1 Europe Europe Cosmetic Surgery Market, by Gender, 2024 – 2033 (USD Million)
- 8.6 Europe Europe Cosmetic Surgery Market, by End-User, 2024 – 2033
- 8.6.1 Europe Europe Cosmetic Surgery Market, by End-User, 2024 – 2033 (USD Million)
- Chapter 9. Company Profiles
- 9.1 Allergan plc
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 Galderma S.A.
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Mentor Worldwide LLC (Johnson & Johnson)
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 Merz Pharma GmbH & Co. KGaA
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Sientra Inc.
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Polytech Health & Aesthetics GmbH
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Cynosure LLC (Hologic Inc.)
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Cutera Inc.
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Syneron Medical Ltd. (Candela Corporation)
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 Alma Lasers Ltd.
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 Lumenis Ltd.
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 Straumann Group
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 Teoxane Laboratories
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 Laboratories Vivacy SAS
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 Sinclair Pharma plc
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 Others.
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.1 Allergan plc
List Of Figures
Figures N0 1 to 31
List Of Tables
Tables No 1 to 2
Report Methodology
In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:
Preliminary Data Mining
On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.
Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.
Statistical Model
Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.
Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.
Some of the variables taken into account for forecasting are as follows:
• Industry drivers and constraints, as well as their current and projected impact
• The raw material case, as well as supply-versus-price trends
• Current volume and projected volume growth through 2033
We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.
Primary Validation
This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.
Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.
All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:
• Market leaders
• Suppliers of raw materials
• Suppliers of raw materials
• Buyers.
The following are the primary research objectives:
• To ensure the accuracy and acceptability of our data.
• Gaining an understanding of the current market and future projections.
Data Collection Matrix
| Perspective | Primary research | Secondary research |
| Supply-side |
|
|
| Demand-side |
|
|
Market Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|
|
Prominent Player
- Allergan plc
- Galderma S.A.
- Mentor Worldwide LLC (Johnson & Johnson)
- Merz Pharma GmbH & Co. KGaA
- Sientra Inc.
- Polytech Health & Aesthetics GmbH
- Cynosure LLC (Hologic Inc.)
- Cutera Inc.
- Syneron Medical Ltd. (Candela Corporation)
- Alma Lasers Ltd.
- Lumenis Ltd.
- Straumann Group
- Teoxane Laboratories
- Laboratories Vivacy SAS
- Sinclair Pharma plc
- Others
FAQs
The key factors driving the Market are Rising Disposable Income, Aging Population, Technological Advancements, Growing Acceptance and Social Influence, Medical Tourism, Expansion of Non-Invasive Treatments.
The “Surgical Procedures” category dominated the market in 2023.
The key players in the market are Allergan plc, Galderma S.A., Mentor Worldwide LLC (Johnson & Johnson), Merz Pharma GmbH & Co. KGaA, Sientra Inc., Polytech Health & Aesthetics GmbH, Cynosure LLC (Hologic Inc.), Cutera Inc., Syneron Medical Ltd. (Candela Corporation), Alma Lasers Ltd., Lumenis Ltd., Straumann Group, Teoxane Laboratories, Laboratories Vivacy SAS, Sinclair Pharma plc, Others.
The market is projected to grow at a CAGR of 10.2% during the forecast period, 2024-2033.
The Europe Cosmetic Surgery Market size was valued at USD 23,853.7 Million in 2024.